Richard Pzena’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,662
Closed -$298K 156
2025
Q1
$298K Sell
2,662
-561
-17% -$57.9K ﹤0.01% 139
2024
Q4
$298K Buy
3,223
+599
+23% +$53.9K ﹤0.01% 141
2024
Q3
$220K Sell
2,624
-1,965
-43% -$150K ﹤0.01% 156
2024
Q2
$315K Sell
4,589
-1,641
-26% -$110K ﹤0.01% 154
2024
Q1
$456K Buy
6,230
+359
+6% +$27.6K ﹤0.01% 148
2023
Q4
$476K Sell
5,871
-130
-2% -$10.1K ﹤0.01% 147
2023
Q3
$450K Buy
6,001
+56
+0.9% +$4.31K ﹤0.01% 146
2023
Q2
$458K Buy
5,945
+2,351
+65% +$188K ﹤0.01% 145
2023
Q1
$298K Buy
+3,594
New +$298K ﹤0.01% 156
2022
Q1
Sell
-3,404
Closed -$247K 182
2021
Q4
$247K Sell
3,404
-4,720
-58% -$325K ﹤0.01% 168
2021
Q3
$567K Buy
8,124
+3,700
+84% +$260K ﹤0.01% 146
2021
Q2
$305K Sell
4,424
-5,881
-57% -$393K ﹤0.01% 160
2021
Q1
$666K Buy
10,305
+232
+2% +$15K ﹤0.01% 149
2020
Q4
$587K Buy
10,073
+1,968
+24% +$119K ﹤0.01% 154
2020
Q3
$512K Buy
+8,105
New +$562K ﹤0.01% 157
2020
Q1
Sell
-7,581
Closed -$493K 175
2019
Q4
$493K Hold
7,581
﹤0.01% 165
2019
Q3
$480K Buy
+7,581
New +$496K ﹤0.01% 164
2017
Q4
Sell
-2,869
Closed -$232K 158
2017
Q3
$232K Buy
+2,869
New +$219K ﹤0.01% 147

Other funds holding GILD

Richard Pzena's GILD Position: Q2 2025 in Review

Richard Pzena sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,662 shares — an estimated $298K sold.

Richard Pzena first reported a position in GILD in Q3 2017 and held it in 18 quarters. The position peaked at $666K in Q1 2021. 2,025 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Richard Pzena reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Richard Pzena sold 2,662 Gilead Sciences shares in Q2 2025, an estimated $298K.
  • Richard Pzena first reported a position in Gilead Sciences in Q3 2017 and held it in 18 quarters.
  • Richard Pzena's Gilead Sciences position peaked at $666K in Q1 2021.
  • 2,025 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Pzena Investment Management's 13F filing for Q2 2025, filed 25 Jul 2025.